ReviewToxicological sciences : an official journal of the Society of Toxicology2025

Tolvaptan safety in autosomal-dominant polycystic kidney disease; a focus on idiosyncratic drug-induced liver injury liabilities.

Sean Hammond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.